Oncolytic Viruses

An oncolytic virus could be a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumors.Many number of viruses such as adenovirus, measles, simplex, Newcastle disease viruses have been clinically tested as oncolytic agents. Most current oncolytic viruses’ area unit designed for growth property, although there are naturally occurring examples such as reovirus and the senecavirus, resulting in clinical trials. The first oncolytic virus to be approved by a national social unit was genetically unqualified ECHO-7 strain animal virus RIGVIR, approved in Republic of Latvia in 2004 for the treatment of skin malignant melanoma.

 

    Related Conference of Oncolytic Viruses

    April 16-17, 2021

    3rd World Congress on Gastroenterology

    Toronto, USA
    April 26-27, 2021

    16th Euro-Global Gastroenterology Conference

    London, UK
    May 26-26, 2021

    International Conference on Hepatitis

    London, UK
    June 14-15, 2021

    International Conference on Gastroenterology and Liver

    Amsterdam, Netherlands
    June 14-15, 2021

    International Congress on Viral Hepatitis

    Rome, Italy
    July 13-14, 2021

    International Conference on Hepatitis & Liver diseases

    Shanghai, Australia
    July 20-21, 2021

    20th World Gastroenterologists Summit

    Osaka, Japan
    August 05-06, 2021

    Global Congress on Pancreas

    Zurich, Switzerland
    September 27-28, 2021

    8th Global Conference on Mass Spectrometry

    Tokyo, Japan
    September 28-29, 2021

    2 nd World Congress on Oil and Gas Engineering

    Auckland, Newzealand
    November 23-24, 2021

    World Conference on Digestive and metabolic diseases

    Hanoi, Vietnam

    Oncolytic Viruses Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in